T he MHC is the genetic region with the most associations with disease in humans. Much of this preponderance of genetic association is due to the classical MHC molecules, which bind proteolytic fragments of proteins and present these peptides (called epitopes) to T lymphocytes of the immune system (1, 2) . The classical MHC molecules have high levels of allelic polymorphism and sequence diversity, thought to be driven mostly by a molecular arms race with pathogens (3) . Most of the sequence diversity is located in and around the peptide binding site, which allows each allele to present different peptides (4) (5) (6) (7) .
Nearly all of the detailed work leading to this description of the MHC, MHC molecules, and Ag presentation has been developed from experiments in humans and mice. However, the enormous global poultry industry has keen interests in the genetics and mechanisms of responses to pathogens and vaccines, and much evidence for MHC determination of resistance and susceptibility to pathogens is from work with chickens. Over decades of experimentation, it has been found that some MHC haplotypes (including B21) generally confer resistance to a variety of infectious viral diseases, whereas other haplotypes (such as B4, also known as B13) often confer susceptibility (8) (9) (10) (11) .
Compared to mammals, the region containing the classical MHC molecules in chickens (variously called "BF-BL region," "classical MHC," or "core MHC") is simple and compact, with only a single classical class I molecule and a single class II molecule expressed at high levels (12) (13) (14) (15) (16) (17) (18) . The chicken MHC is also organized differently than the MHC of typical mammals. In particular, the genes for the TAP, a peptide transporter that pumps peptides from the cytoplasm to the lumen of the endoplasmic reticulum for loading onto class I molecules, are polymorphic and very closely linked with the class I genes, with coevolution resulting in a single dominantly expressed class I molecule (19) . The "minimal essential MHC" hypothesis proposes that the properties of the single dominantly expressed class I and class II molecules are responsible for the strong genetic associations with pathogen and vaccine responses, in comparison with typical mammals with a multigene family of MHC molecules (13, 14) . Moreover, evidence suggests that many if not most nonmammalian vertebrates have the salient properties discovered in chickens (20) .
Peptide motifs for the classical class I molecules from chicken blood cells of a few chicken MHC haplotypes have been determined and can explain the resistance and susceptibility of chickens to economically important viral diseases such as Rous sarcoma virus and Marek's disease virus (MDV) (14, 15, 18) . These chicken peptide motifs look very different from those reported for humans, mice, and rats, as most mammalian motifs are nonamer peptides with two so-called anchor residues at which only a few related amino acids are used to bind into deep pockets of the class I molecule (4) (5) (6) (7) .
The peptides from chicken BF2*2101 on blood cells (BF2 is the gene name; 2101 is the allele) are mostly 10mers and 11mers, with covariation of anchor (and other) residues such that an astonishing variety of peptides will bind. The structure of BF2*2101 (15) , the only one for a classical class I molecule outside of mammals, shows that it is the interplay of arginine at MHC position 9 (R9, where R is the single-letter amino acid code for arginine) and aspartic acid at MHC position 24 (D24) within a very wide binding groove that allows the BF2*2101 molecule to remodel its binding site to accommodate peptides with completely different sequences.
The peptides from all other chicken MHC molecules on blood cells (14, 18) are almost exclusively octamers, and most have only one or two closely related amino acids specified in each of three anchor positions. BF2*0401 is one such molecule, with a peptide motif of aspartic acid (D) or glutamic acid (E) at peptide position 2, D or E at position 5, and E (with a low level of hydrophobic amino acids) at position 8 (i.e., DE2-DE5-E8). This motif is quite fastidious, and in fact the B4 (also called B13) haplotype in the BF-BL region is often associated with susceptibility to particular pathogens, presumably because no protective peptide from the pathogen can be presented (14, 18) . In this study, the crystal structure of BF2*0401 is reported and shown to explain much of the specificity of the molecule. However, peptide-binding studies show that BF2*0401 can bind a wider variety of peptides than is found on the surface of cells. This observation, in conjunction with previous work on TAP specificities (19) , shows that chicken TAP molecules can restrict the peptides actually presented to the immune system.
Materials and Methods

Peptide synthesis
The octamer IE8 from FUS proto-onc gene (18) and 22 peptides with single, double, or triple substitutions (see Table II ) were synthesized using an Apex 396 peptide synthesizer and purified by HPLC reverse phase chromatography (SciLight Biotechnology).
Protein preparation
DNA fragments encoding extracellular domains of BF2*0401 (Genbank: AM282693, residues 1-270 of the mature protein with restriction sites EcoRI and HindIII) and chicken b 2 -microglobulin (b2m) (Genbank: AB178590, residues 1-98 of the mature protein) were cloned into pET21a (+) vectors and expressed in Escherichia coli BL21 (DE3) pLysS (Novagen). The BF2*0401 and b2m inclusion bodies were prepared essentially as previously described by Garboczi and others with minor modifications (21) (22) (23) . After refolding with IE8 (and substituted peptides), the monomers were purified using a Superdex 200 16/60 column, followed by Resource Q anion-exchange chromatography (GE Healthcare). Purified proteins were buffer-exchanged with 10 mM Tris-HCl, 10 mM NaCl, pH 8.
Crystallization and data collection
Mixed with reservoir buffer at a 1:1 ratio, the purified proteins were screened for crystallization trials using the hanging-drop vapor-diffusion method with Crystal Screens I and II (Hampton Research) at 291 K. Crystals (BF2*0401-IE8, BF2*0401-P8D, and BF2*0401-P5E) from protein concentration 10 mg/ml were observed in 0.1 M HEPES buffer (pH 7, 5% MPD and 20% PEG6000). Data collection was performed on a Rigaku MicroMax007 rotating-anode x-ray generator operated at 40 kV and 20 mA (Cu ka; l = 1.5418 Å ) equipped with an R-AXIS VII++ image-plate detector. Diffraction data collected (Table I) was indexed and scaled using HKL2000 (24) .
Structure determination and refinement
The crystal of BF2*0401-IE8 belongs to the C2 space group with unit cell constants a = 166.20 Å , b = 40.29 Å , c = 131.59 Å , a = g = 90.00˚, b = 119.71˚(see Table I ). The structure was determined by molecular replacement using Molrep and Phaser in the CCP4 package, with BF2*2101-11mer structure [Protein Data Bank (PDB) code: 3BEV, with the peptide excluded] as the search model (25) (26) (27) . Residues that differ between BF2*0401 and the search model were manually rebuilt in the program Coot under the guidance of 2Fo-Fc and annealed omit maps, varying with the reciprocal space refinement in Refmac5 (27) (28) (29) . After adding peptide, subsequent refinements were conducted for energy minimization, individual B factor restriction, and water molecule addition, with non-crystallographic symmetry restraints applied to the two copies of BF2*0401-IE8/P8D/P5E in the asymmetric unit. Ramachandran plot and secondary structure assignments were generated by SFCHECK (30) . The final structure was composed of two BF2*0401-IE8 complexes, with R factor = 19.7% and R free = 25.5%, and the two copies both contained residues 1-270 of BF2*0401 and 1-97 of b2m. The structures of mutant peptides P8D and P5E were determined using BF2*0401-IE8 as the model (see Table I ). The atomic coordinates of the crystal structures of BF2*0401-IE8/P8D/P5E have been deposited in the PDB (http://www.pdb.org/pdb/home/home.do) with accession number 4E0R (http://www.rcsb.org/pdb/search/structidSearch.do? structureId=4E0R), 4G42 (http://www.pdb.org/pdb/search/structidSearch.do? structureId=4G42), and 4G43 (http://www.pdb.org/pdb/search/structidSearch. do?structureId=4G43), respectively.
Structural analysis and generation of illustrations
Peptide-contacting residues were identified using the program CONTACT and were defined as residues containing an atom within 3.3 Å of the target partner (25) . Structural illustrations and electrostatic potential surfaces were generated using the PyMOL molecular graphics system (DeLano Scientific; http://www.pymol.org).
Determination of complex thermostability using CD spectroscopy
The thermostabilities of BF2*0401 with seven mutant peptides were tested by circular dichroism (CD) spectroscopy. CD spectra were measured at 20˚C on a Chirascan spectropolarimeter (Applied Photophysics) equipped with a water-circulating cell holder. The protein concentration was 7 mM in pH 8 Tris buffer (20 mM Tris and 50 mM NaCl). Thermal denaturation curves were determined by monitoring the CD value at 218 nm by using a 1-mm optical pathlength cell as the temperature was raised from 25˚C to 94˚C at a rate of 1˚C/min. The temperature of the sample solution was directly measured with a thermistor. The fraction of unfolded protein was calculated from the mean residue ellipticity (u) by the standard method. The unfolded fraction (%) is expressed as (u 2 u N )/(u U 2 u N ), where u N and u U are the mean residue ellipticity values in the fully folded and fully unfolded states. The midpoint transition temperature (T m ) was determined by fitting data to the denaturation curves using the Origin 8.0 program (OriginLab).
Results
Overall structure of chicken BF2*0401 and its comparison with other MHC molecules
The crystal structure of BF2*0401 bound to peptide IE8 (IDWFDGKE from Ref. 18 ) was solved by molecular replacement using the BF2*2101 structure (PDB code: 3BEV) as a search model, with data collection and refinement statistics of the crystal structure listed in Table I . There are two BF2*0401-IE8 molecules per asymmetric unit. The overall structure is similar to that of the previously determined BF2*2101. Briefly, the a1 and a2 domains together form the binding groove, with two a-helices atop an eight-stranded b-sheet. The a3 domain and the noncovalently associated L chain b2m beneath the a1/a2 platform have Ig-like folds and consist primarily of antiparallel b-sheets. The IE8 peptide binds to the groove at the top of the BF2*0401 molecule in a position to interact with the TCR (Fig. 1A) .
Superposition demonstrates that the BF2*0401 structure closely agrees with the BF2*2101 (3BEV with one structure, 3BEW with
The Journal of Immunology two structures), with root-mean-square deviation (r.m.s.d.) between Ca positions of a1/a2 domains of 0.727 Å , and an identical orientation of the b2m domains ( Fig. 1B) . However, the A-B loop of the a3 domain in BF2*0401 is much like the structure of mammalian class I molecules, unlike the large rotation seen for all three structures of BF2*2101 (Fig. 1C ). In any case, the two residues Q222(226) and D223(227) (amino acid positions are with and without parentheses for human and chicken classical class I H chains, respectively) predicted to be most involved in binding the coreceptor CD8 are conserved (31) (32) (33) (34) .
Compared to the chicken BF2*2101 molecule, BF2*0401 has a very narrow groove Similar to most mammalian classical class I molecules but unlike BF2*2101, BF2*0401 has distinct pockets named A-F ( Fig. 2A -C). At the N terminus of IE8, the main-chain atoms of P1 Ile make strong hydrogen bonds with the side chains of Y7, Y156, and Y168 in the A pocket. This network of interactions is highly conserved in BF2*2101 and most mammalian MHC class I molecules. The Tyr(84) invariant among mammalian classical class I molecules is replaced with an R83 in pocket F of BF2*0401 (as in all other nonmammalian vertebrates) ( Fig. 2F ).
Pocket B in many (although not all) mammalian class I molecules is very deep (35) (36) (37) (38) , reaching under the a1 helix so that the peptide P2 residue touches residue 45, one of the most polymorphic residues of mammalian class I molecules. In contrast (Figs. 2, 3C), pocket B in BF2*0401 is relatively shallow with accessibility to the equivalent position Y43(45) mostly blocked off by the T24 (24) . In BF2*0401, pocket B is formed by T24(24), Y43(45), Q62(63), and I65(66), along with R9(9), which is shared with pocket C. This relatively shallow pocket is similar in BF2*2101, but as discussed later, the boundary of pockets B and C is more rigid in BF2*0401.
The C, D, and E pockets in the center of the groove are far better defined in BF2*0401 than in BF2*2101 (Figs. 2, 3D). Pocket C includes N69(70), N73(74), W95(97), and R111(114), along with R9(9). In addition, L68(69), N69(70), F97(99), and R111(114) pointing up from the b-sheet of the a2 domain divide pockets C, D, and E into small separated sections. Finally (Figs. 2, 3E ), pocket F is narrower and shallower in BF2*0401 than either BF2*2101 or other mammalian class I molecules, with the sides lined with N76(77), I79(80), R83(84), and T140(143), and the very bottom occupied mainly by R80(81) with some contribution of F120(123) and I121(124).
Compared to BF2*2101, BF2*0401 has a much narrower groove, particularly after pocket B, toward the carboxyl end of the peptide (Figs. 2A-2E, 4A, 4B). The nearest and farthest distances between the cavity walls are 7.00 Å and 10.23 Å for BF2*0401-IE8 compared with 12.12 Å and 14.42 Å for BF2*2101-11mer. Indeed, the groove of BF2*0401 seems narrower even in comparison with mammalian class I molecules.
The main-chain atoms of the a1/a2 platform of BF2*0401 and BF2*2101 are nearly superimposable ( Fig. 4C ), so that the narrow groove of BF2*0401 and the wide groove of BF2*2101 are due entirely to the different side chains of amino acids pointing into the groove. In particular, the large residues L68(69) and N69(70) from the a1 helix and R152(155) and W153(156) from the a2 helix of BF2*0401 are replaced by the much smaller G68(69), S69(70), G152(155), and L153(156) in BF2*2101 ( Fig. 4A, 4B , 4D). These large overhanging residues along with bulky side chains of F97(99) and R111(114) constrain the position of R9(9) to stand up straight, high and relatively rigid in BF2*0401. In contrast, R9 (9) is free to adopt various conformations in the wider groove of BF2*2101, allowing the remodeling of the groove to accept peptides of completely different sequences ( Fig. 4E, 4F) .
A unique positively charged groove of BF2*0401 binds several negatively charged anchor residues of the peptide In typical mammalian classical class I molecules, the peptides are nonamers tightly bound at the N and C termini into pockets A and F, respectively, and with extensive interactions of their anchor residues at position 2 and the final position into deep pockets B and F, respectively. The peptide rears up out of the groove after position 2, so that pockets C, D, and E are generally shallower and bind socalled secondary anchor residues (4-7). Some features of the IE8 peptide are similar to the typical pattern in mammals, but some are strikingly different. The N-terminal amino group and C-terminal carboxy group bind to the extensive H-bond networks in pockets A and F. However, the IE8 peptide lies flatter than most peptides in mammalian class I molecules as well as in BF2*2101 (Fig. 4E ). Indeed, IE8 lies even flatter than octamer peptides presented by mammalian MHC molecules, including K b -SIINFEKL. The IE8 octamer does not rear up out of the groove in BF2*0401 as much as the nonamers typically found in mammals, and far less than the 10mer and 11mer in BF2*2101. The IE8 peptide also does not sink down so far back into the groove at the C-terminal end as in BF2*2101 due to a bulky side chain of R80(81) at the bottom of the F pocket. Pockets B, C, D, and E are shallow, contributing to the more extended conformation of the bound peptide.
As predicted from the sequence and model (18) , the structure of BF2*0401 shows that there are several arginines located in the peptide binding site (Fig. 3A) . Indeed, the whole groove is strongly positively charged (Fig. 3B) , unlike any mammalian class I molecule for which the structure is known (Fig. 5 ). Three arginines point upwards from the b-sheet of the groove, all of which interact with the peptide anchor residues. R9(9) in pocket B makes two salt bridges with peptide position D2, along with a hydrogen bond from Y43 (45) and two hydrogen bonds with the main chain from Q62(63) (Fig. 3A, 3C ). R9 (9) and R111(114) in pocket C both make salt bridges with peptide position D5, along with a hydrogen bond with the main chain from N69(70) (Fig. 3A, 3D ). R80(81) in pocket F makes two salt bridges with peptide position E8, along with a hydrogen bond from N76(77) (Fig. 3A, 3E ). These interactions are consistent with the negative charges found at positions 2, 5, and 8 in the motif determined for B4 cells. Some B4 peptides (but not IE8) also have a negatively charged residue at P4, which would interact with R152(155) on the a2 helix. Also, a very few peptides found on B4 cells have a hydrophobic amino acid at the C terminus, which is compatible with the lining of pocket F by hydrophobic amino acids I79(80), F120(123), and I121(124). Thus, the structure of BF2*0401 bound to IE8 would appear to explain the peptide motif found for B4 cells.
Compared to the peptides found on B4 cells, BF2*0401 binds a wider variety of peptides in vitro
The sequence motif for peptides presented by B4 cells was determined by eluting peptides from BF2*0401 isolated from erythrocytes and spleen cells and sequencing both individual peptides and pools of peptides (14, 15, 18) . All experiments gave the same answer: the peptides were octamers with mostly aspartic acid (and some glutamic acid) at positions 2 and 5 and glutamic acid (and a very low level of some hydrophobic amino acids) at position 8.
To verify that the peptide motif is determined by the binding specificity of the BF2*0401 molecule, renaturation of the H chain, b2m, and synthetic peptides followed by size exclusion chromatography (gel filtration) was performed (Table II, Fig. 6 ). The original peptide IE8 (D2-D5-E8) gave a high yield of refolded material at the size expected for a monomer (i.e., H chain, b2m, and peptide). Single substitutions of negatively charged residues at the anchor residues (E2-D5-E8, D2-E5-E8, D2-D5-D8) also gave high yields, but double substitutions led to lower yields, and the triple substitution (E2-E5-D8) did not yield a monomer peak. Single substitutions of alanine at the anchor residues of IE8 gave high yields for one peptide (D2-A5-E8) but lower yields for the other two peptides (A2-D5-E8, D2-D5-A8) and no monomer peak for any alanine substitutions of the charge-substituted peptides. Finally, substitution at peptide position 5 with large residues (D2-R5-E8, D2-Y5-E8, and D2-F5-E8) resulted in no binding.
The binding stabilities of peptide IE8 and several substitutions were further analyzed by CD spectra (Fig. 7A) , with the T m s determined from melting curves. Five BF2*0401 complexes are very stable, with T m s approximately 62˚C. Three complexes (peptides IE8, D2-D5-E8; P5E, D2-E5-E8; and P8D, D2-D5-D8) have steep curves which are almost overlapping, with T m of approximately 62˚C and starting unfolding temperatures of nearly 50˚C. Two other complexes (P2E, E2-D5-E8 and P5A, D2-A5-E8) are also very stable with T m s of approximately 62˚C, but with shallower curves and starting unfolding temperatures of 40˚C and 35˚C, respectively. Finally, two low-yield complexes (P8A, D2-D5-A8 and P2E5E, E2-E5-E8) are not very stable, with T m s of approximately 54˚C and 52˚C, respectively. Thus, the thermostabilities of BF2*0401 complexes with low yield peptides were lower than those of well-refolded peptides, showing that the peptide-binding motif of BF2*0401 is correct.
Thus, the peptide-binding motif of the BF2*0401 molecule is wider than the peptide motif found from B4 cells. For instance, from Table II we predict 11 peptides from four MDV proteins will bind BF2*0401, but the motif based on peptides eluted from cells predicts only three peptides (15) . The fact that large amino acids in position 5 did not support renaturation is consistent with the narrow groove at that position. However, the finding that aspartic acid at position 8 would support renaturation (when one of the other two positions was an aspartic acid) was unexpected. Furthermore, the finding that alanine in any of the three anchor positions would support renaturation was also unexpected. These results argue for some but not total flexibility in the binding site and suggest that the peptides supplied to the class I molecule are restricted in this MHC haplotype.
To elucidate the different roles of the major anchor residues of IE8 (D2-D5-E8) binding to BF2*0401, we determined the crystal structures of BF2*0401 with peptides P8D (D2-D5-D8) and P5E (D2-E5-E8), at 2.3 Å and 1.8 Å , respectively (Table I ). The three structures were similar overall, as assessed by the positions of main-chain carbon atoms in pairwise superimposition (r.m.s.d. of 0.153 Å for BF2*0401-P8D aligned with BF2*0401-IE8, and 0.264 Å for BF2*0401-P5E aligned with BF2*0401-IE8).
However, the three structures differed in the main-chain conformation of the peptides (Fig. 7B) , even though the BF2*0401 residues comprising the C and F pockets retain similar conformations. Comparison of the peptides IE8 and P8D shows that the main-chain carbon atom of Asp8 of P8D drops 1.25 Å compared to Glu8 in IE8, so that the side chains reach the same depth such that the salt bridge and hydrogen bonds remain the same, maintaining the peptide-binding affinity. In particular, the residue R80(81) in pocket F of BF2*0401 adopts the same conformation in both structures (Fig. 7C, 7D ). In the same way, the Glu5 in P5E and Asp5 in IE8 form a similar salt and hydrogen bonds with residues R9(9), N76(77), and R111(114) in the C pocket of BF2*0401, with the main chain of P5E raised about 1.22 Å at this point (Fig. 7E, 7F) .
The structural analysis of these three BF2*0401 structures explains the binding affinity profiles shown in Table II . The narrow peptide-binding groove including the major pockets of BF2*0401 retains the rigid conformation, so that peptides modify their conformation to adapt to the pockets. We find that a substitution of Asp to Glu at peptide position 5 leads to a rise in the main chain in the middle of the peptide, while substitution of Glu to Asp at position 8 leads to lowering of the main chain at the end of the peptide. Based on these observations, it is likely that other peptides with two substitutions will also retain some binding affinity by minor conformational changes of the main chain. Such minor adjustment by the main chain would also allow peptides with single Ala substitutions to refold with BF2*0401.
Discussion
The structure of the classical class I molecule BF2*0401 in complex with the self-peptide IE8, along with the binding assays (D and E) The surface of the BF2*0401-IE8 binding groove is superimposed onto that of BF2*2101-11mer (D) or BF2*2101-10mer (E). BF2*0401 is shown in pink, and BF2*2101-11mer and BF2*2101-10mer are colored in cyan and orange, respectively. (F) Structurebased amino acid sequence alignment of the a1-a2 domains of BF2*0401 and BF2*2101, with the secondary structure elements indicated above. The cysteine residues involved in the first disulfide bond are marked by a green "1." Conserved residues are highlighted in red. Residues forming the binding groove are marked by orange stars for BF2*0401 and blue stars for BF2*2101. of substituted peptides, goes a long way toward explaining the peptides presented by the chicken B4 haplotype. Four points illuminate principles of MHC-peptide interaction either unusual or not found at all in humans and other mammals, each of which leads to questions requiring further study.
First, in contrast to many classical class I molecules in humans and mice, cells of the B4 haplotype present octamer peptides with the motif DE2-DE5-E8 (with small amounts of hydrophobic amino acids at peptide position 8). The structure of BF2*0401 shows that the peptide-binding groove is flatter and shallower than those of typical mammals, with no deep pocket B leading to the equivalent of human residue 45. On the basis of peptide motifs determined for certain other chicken class I molecules (such as B12, B15, and B19) and simple wire models (and consistent with the structure of BF2*2101 for pocket B) (14, 15, 18) , this is likely to be a general feature of chicken classical class I molecules. Second, the center of the groove is narrower compared with BF2*2101, being filled and even overhung by the large residues L68(69), N69(70), R152(155), and W153(156). Similarly, large residues are found in the sequences of the dominantly expressed class I molecules from the B6, B12, B15, and B19 haplotypes (16, 18) , so this is also likely to be a feature of many chicken classical class I molecules.
Third, three positively charged residues [R9(9), R80(81), and R111(114)] point up from the b-strands that make up the floor of the binding groove, along with another [R152(155)] pointing in from the a2 helix. The resulting groove is extremely positively charged, which should explain the negatively charged peptide motif determined from B4 cells. Although there are mammalian class I molecules with negatively charged anchor residues (notably H-2K k , HLA-A1, B37, B38, B40, and B44), BF2*0401 is the only class I molecule reported with more than one negatively charged anchor residue. Moreover, it is the only class I molecule reported with a negatively charged anchor residue in the C-terminal position. Indeed, the constitutive proteasome specificity in mammals is altered to the immunoproteasome by replacing constitutive components, which include a peptidyl-glutamyl peptide-hydrolyzing activity, with the inducible proteasome components, which cleave poorly after acidic residues (39, 40) . Inducible proteasome components have not yet been identified in chickens, but if they do exist it is likely that they cleave after acidic residues, at least in the B4 haplotype.
Fourth, perhaps the most important point to come out of this analysis is the fact that the peptide-binding specificity found by renaturation assays is wider than the peptide motif from B4 cells. Because the specificity of the TAP molecule from the B4 haplotype matches the peptide motif (18, 19) , it is clear that the B4 TAP is restricting the peptides that reach the endoplasmic reticulum to load onto class I molecules. In contrast, TAP genes in typical mammals have no functional polymorphism, instead pumping a wide range of peptides from which the particular class I molecules present select the peptides to bind (41, 42) . In rats, there are two allelic lineages of the TAP2 gene that affect the translocation specificity of peptides depending on the C-terminal amino acid. In this species, it is reported that the peptide-binding specificity of the class I molecule(s) converge with the translocation specificity of the TAPs (41, 43) . Thus, the restriction of peptides by the translocation specificity of TAP alleles in chickens has never been described in mammals. The other components in the Ag processing/ presentation pathway may also contribute to the restricted B4 haplotype peptide repertoire, which need further exploration.
The fact that at least some alleles of the polymorphic chicken TAP molecules restrict the peptides loaded onto the dominantly expressed class I molecule has some profound implications. It may be that the grooves of many chicken class I molecules are generally shallower than those in typical mammals, with the peptide-binding specificities correspondingly less fastidious. Moreover, more and different peptides might be presented by a dominantly expressed class I molecule in an MHC heterozygote compared with a ho- In the in vitro refolding assay, if an elution peak representing the peptide-BF2*0401 complex appears in gel filtration, the peptide is defined as being able to bind to BF2*0401, with +++ indicating that the refolding efficiency was comparable to that of wild-type IE8 and the complex was stably eluted under anion-exchange conditions, ++ indicating that the refolding efficiency was ∼50-60% that of IE8 and the complex partially dissociated under anion-exchange conditions, + indicating that the refolding efficiency was much lower than that of IE8 and the complex was not stable under anion-exchange conditions, and -indicating no refolded product. FIGURE 6. Refolding of BF2*0401 and b2m with IE8 and its mutants. Peptide-induced assembly and stabilization assay of BF2*0401 molecules by in vitro refolding. (A) Gel filtration chromatograms of the refolded products. Peak 1, peak 2, and peak 3 represent the aggregated H chain, the correctly refolded BF2*0401 complex (45 kDa) , and the extra b2m, respectively. The refolding efficiencies are represented by the relevant concentration ratio and height of peak 2 for IE8 and each mutant. A high peak 2 refers to the better efficiency of the peptide to help the MHC renature. Otherwise, if little or no peak 2 is observed, the peptide cannot be considered to stabilize the complex, and therefore is treated as a nonpresenting peptide. The IE8 mutants are listed in Table II . (B) Results of further stabilization assays of the refolded complexes by anion exchange. Under the anion-exchange conditions, complexes of IE8, P5A, P2E, P5E, and P8D can be eluted normally at an NaCl concentration of 15-17% (peak 1). With the peptides of P8A, P2E5E, P2A, P5E8D, and P2E8D, the refolded complex proteins can be partially dissociated at an NaCl concentration of 18-20% (peak 2), implying less stability. mozygote, adding a new dimension and power to the notion of MHC heterozygote advantage compared with typical mammals.
Indeed, this may explain the peptide motif reported for the BF2*1301 molecule (identical in sequence to BF2*0401) transfected into RP9 cells that are derived from a B2/B15 heterozygote chicken (44) . This motif looks like the BF2*0401 motif, but with a penultimate acidic residue often followed by a C-terminal hydrophobic residue. These results are easily understood if, in the absence of the appropriate TAP molecule, peptides with a Cterminal hydrophobic residue were translocated into the endoplasmic reticulum, but only peptides with the requisite acidic residues bound to the BF2*1301 molecule, with the C-terminal hydrophobic residue hanging out the end of the groove, as has been seen occasionally in structures of human class I molecules (45) . Further experiments are needed to understand the general principles of this coevolutionary interaction. Finally, the structure of BF2*0401 (along with the peptidetranslocation motif of TAP in B4 cells) leads to a truly fastidious motif at the cell surface for presentation of peptides to T cells. Thus, there are generally few peptides presented by the class I molecule of B4 cells, leading to susceptibility to pathogens whose sequences contain no protective peptide with the right motif. Indeed, B4 (and B13) haplotypes are generally reported to confer susceptibility to a variety of infectious pathogens. However, these haplotypes are not rare in the chicken populations, so there must be some selective pressure leading to their relatively high gene frequency. Whether this is due to selective breeding, to resistance conferred to some important (strains of) pathogen(s), or to some other selective pressure is the subject of ongoing investigations.
